GenturaDx

This article was originally posted on Sept. 12.
Luminex has no plans to acquire any new businesses or companies at this time, its CEO Patrick Balthrop said at an investment conference last week.

Luminex this week provided investors with additional details regarding the planned expansion of its molecular diagnostics business to tap into the laboratory-developed test market and to serve customers seeking a platform with higher throughput and lower multiplexing than Luminex

Luminex this week provided investors with an update on its molecular diagnostics pipeline, including the integration of recently acquired GenturaDx and its sample-to-answer testing platform and the market uptake and opportunity for its xTAG Gastrointestinal Pathogen Panel.

NEW YORK (GenomeWeb News) – Luminex today disclosed the finances of GenturaDx, a molecular diagnostic test firm that it acquired for $50 million during the summer.

NEW YORK (GenomeWeb News) – Luminex has completed the acquisition of molecular diagnostics firm GenturaDx for $50 million in cash plus potential additional consideration based on milestones and/or product revenue performance.

Luminex this week made a play for the low- to mid-volume molecular diagnostic testing market by when it announced that it is acquiring privately held molecular diagnostics developer GenturaDx for $50 million.

NEW YORK (GenomeWeb News) – Luminex has signed a definitive agreement to acquire molecular diagnostics firm GenturaDx for $50 million in cash and potential additional consideration based on milestones and/or product revenue performance.

Gen-Probe has been awarded US Patent No. 8,145,435, "Real-time amplification and monitoring system incorporating vector-based algorithm for analyzing polynucleotide-containing samples."

ArcticZymes has named Brent Spoth as business development manager for the Americas.

PrimeraDx announced the appointment of David Heffelfinger as VP of engineering and systems development.

Pages

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.